Folate for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Folate for Health & Longevity

Created on 08/24/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Folate is an essential vitamin, and the case for taking extra depends almost entirely on whether a person is already short of it. Correcting a shortage is cheap, safe, and worthwhile. Where none exists, further gain thins quickly. Harms cluster at a milligram or more: hiding a vitamin B12 shortage, and a small, inconsistent rise in cancer diagnoses. (Full Review)

Protocol

Standard maintenance dose
400 µg daily
L-5-MTHF or folic acid, matching the 400 µg dietary folate equivalents allowance
Deficiency correction dose
1–5 mg daily
One to four months for documented deficiency or megaloblastic anaemia, then back to maintenance
Conventional form approach
Folic acid
Public health bodies specify folic acid, since every trial used it; the integrative approach argues for L-5-MTHF
Time to effect
Homocysteine
4–8 weeks
Functional readout of the methylation branch; the presumed stroke route
Red blood cell folate
8–12 weeks
The better status measure; the neural tube defect threshold
Serum folate
Within days
Short-term intake only; the last few days, not tissue stores

Benefits

Contraindications
  • Untreated or undiagnosed vitamin B12 deficiency (serum B12 below 148 pmol/L, or methylmalonic acid above 0.27 µmol/L) until B12 is replaced
  • Pernicious anaemia not yet established on vitamin B12 replacement
  • High-dose methotrexate (500 mg/m² or above) or other antifolate chemotherapy, except under oncology-directed rescue
  • Documented folic acid hypersensitivity or anaphylaxis, including methotrexate cross-reactivity
  • Current colorectal adenoma or untreated prostate cancer, for supplemental doses above 400 µg daily
Key Interactions
  • Low-dose methotrexate (7.5–25 mg weekly)
  • Other dihydrofolate reductase inhibitors (trimethoprim, pyrimethamine, sulfadoxine-pyrimethamine, proguanil)
  • Phenytoin, phenobarbital, primidone
  • Fluorouracil and capecitabine
  • Sulfasalazine and cholestyramine
  • Over-the-counter aspirin and non-steroidal anti-inflammatory drugs (ibuprofen, naproxen)
  • Over-the-counter antacids and acid-suppressing drugs (calcium carbonate, omeprazole, famotidine)
  • Vitamin B12
  • Vitamin B6, riboflavin, and betaine (trimethylglycine)
  • Green tea catechins at extract doses
  • Alcohol
    •

Risk & Side Effects

  • High: Increased cancer incidence at supplemental doses of 1 mg or more
  • Medium: Masking and aggravation of vitamin B12 deficiency; accelerated recurrence of advanced colorectal adenomas
  • Low: Gastrointestinal symptoms; loss of seizure control through lowered phenytoin levels; antagonism of antifolate drug therapy; hypersensitivity reactions
  • Speculative: Increased sperm DNA fragmentation; reduced natural killer cell activity from unmetabolised folic acid; shorter leukocyte telomeres at high folate status; over-stimulation and disturbed sleep on high-dose methylfolate

Monitoring

Marker Target Why
Serum folate 15–25 ng/mL (34–57 nmol/L) Short-term intake
Red blood cell folate Above 400 ng/mL (906 nmol/L) Tissue folate stores
Serum vitamin B12 500–900 pg/mL (369–664 pmol/L) Rules out the masking risk
Methylmalonic acid (MMA) Below 0.27 µmol/L Confirms vitamin B12 sufficiency
Total homocysteine 6–8 µmol/L The functional readout of folate's methylation branch
Complete blood count with mean corpuscular volume (MCV) MCV 82–89 fL Detects megaloblastic change
Serum uric acid Below 357 µmol/L (6 mg/dL) Tracks the secondary metabolic effect
Prostate-specific antigen (PSA) Age-specific: below 2.5 ng/mL under 60, below 4.0 ng/mL over 60 Surveillance where the cancer signal is clearest
Unmetabolised folic acid No established target; track change from own baseline Exposure marker behind the speculative harms

Cadence: Fasting baseline panel; homocysteine and vitamin B12 at eight weeks; red blood cell folate and homocysteine at six months; annually thereafter, or six-monthly above 800 µg daily, over 65, or on an interacting medication

Qualitative Assessment

  • Energy through the afternoon
  • Cognitive clarity and word-finding
  • Mood stability, particularly alongside an antidepressant
  • Sleep onset and quality on high-dose methylfolate
  • Tongue soreness and mouth ulceration
  • Numbness or tingling in the hands or feet
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.